• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Final Report of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39′ Vaccines to Optimize Long-term Antitumor Immunity in Folate Binding Protein (FBP)-Expressing Breast and Ovarian Tumors

John W Myers, MD1, Kaitlin M Peace, MD1, Timothy J Vreeland, MD2, Diane F Hale, MD1, Doreen O Jackson, MD1, Julia M Greene, MD1, Tommy A Brown, MD1, Guy T Clifton, MD1, George E Peoples, MD3, Elizabeth A Mittendorf, MD, PhD2. 1Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, 2The University of Texas MD Anderson Cancer Center, Houston, TX, 3Cancer Vaccine Development Program, San Antonio, TX

OBJECTIVES: E39 (FBP191-199,GALE-301,EIWTHSYKV) is a FBP-derived peptide vaccine shown to be safe and efficacious in a phase I/IIa trial.  Due to concerns of overstimulation with repeated inoculations of one peptide, we developed an attenuated version, E39’(GALE-302,EIWTFSTKV), shown in vitro to enhance E39-specific immunity. Here, we present the final analysis of different vaccine doses/schedules to induce FBP immunity.

METHODS: Disease-free, HLA-A2+ breast (BC, n=35) or ovarian (OC, n=4) cancer patients (pts) were enrolled and randomized to three primary vaccine series (PVS) arms: EE (monthly E39x6); EE’ (E39x3, E39’x3); E’E E39’x3, E39x3). Delayed-type hypersensitivity (DTH) and E39-specific cytotoxic T-lymphocytes (CTL) were assessed throughout the study.  This data was used to assess significant residual immunity (SRI), and patients were sorted into: with SRI (SRI) and without (nSRI). Patients within these groups were randomized to one booster of either E39(E) or E39’(E’). Immunologic and safety data were analyzed.

RESULTS: 30 pts completed the PVS [EE(10),EE’(10),E’E(10)], 28 received boosters [EE-E(5),EE-E’(5), EE’-E(7), EE’-E’(3), E’E-E(3),E’E-E’(5)]. No clinicopathologic differences or related toxicities >grade 2 were appreciated.  There was only an increase in DTH pre- to 6-months post-PVS in the EE’ arm (ΔEE=-7mm, p=0.16; ΔEE’=+33.75mm, p=0.001; ΔE’E=-0.64mm, p=0.48).  There was no difference in DTH pre- to 6-months post-booster among booster groups, however at 1-month post-booster, the EE’-E patients had increased DTH (ΔEE’E=39.43,p=0.02).

CONCLUSION: Both peptides were noted to be safe and immunogenic. The in vivo DTH response was enhanced with the PVS sequence of E39 then E39’, and seems best paired with an E39 booster; this may indicate expansion of effective clonal populations of CD8+ T cells with this strategy.  Further analysis of this combination’s effect on recurrence in a larger phase II trial is justified.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 87878

Program Number: MSS04

Presentation Session: Full-Day Military Surgical Symposium – Basic Science Presentations

Presentation Type: MSSPodium

15

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2018 abstract archive

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
sagesweb@sages.org
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons